you ever invested in biotech or tech looking to commercialise IP. They don’t produce revenue so their only means of progression is raising capital. However 43% of every dollar spent likely palace for R&D grant rebate so that stretches the research dollars 43% further than the technical cash position.
BB1 Price at posting:
26.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)